Metabolix Evaluating Strategic Alternatives for its Specialty PHA Biopolymers Business and Yield10 Bioscience Program
Metabolix Raises $2 Million in Amendment to Licensing Deal with Tepha
Metabolix Announces New Strategic Direction: Yield10 Bioscience to Become Core Business, Biopolymers Operations to be Wound Down
Metabolix Announces $10 Million Binding Letter of Intent for Sale of Biopolymer Assets to CJ CheilJedang
Metabolix Completes $10 Million Sale of Biopolymer Assets to CJ CheilJedang
Metabolix Names Heike Sederoff, Ph.D. to Yield10 Bioscience Scientific Advisory Board
Metabolix and North Carolina State University Enter into Worldwide, Exclusive License Agreement for Advanced Crop Technologies
Dr. Kristi Snell Representing Yield10 at Policy Event Focused on Building a 21st Century Agricultural Workforce